FIRST CHINA PHARMACEUTICAL GROUP, INC. Financing Cash Flow
FIRST CHINA PHARMACEUTICAL GROUP, INC. reported Financing Cash Flow of $3.47 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-11-19
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was $516.92K, a 66.69% decline year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $3.52M, a 14.02% increase year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was -$568.26K.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $1.55M.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net cash provided by (used in) financing activities for fiscal 2011 was $9.56M, a 19091.91% increase from fiscal 2010.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net cash provided by (used in) financing activities for fiscal 2010 was $49.83K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2012-09-30 | $516.92K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $4.03M derived: sum of 2 quarters · filed 2012-11-19 | $3.47M 10-Q · filed 2012-11-19 | ||||
| 2012-06-30 | $3.52M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-21 | $2.95M 10-Q/A · filed 2012-08-21 | |||||
| 2012-03-31 | -$568.26K 10-Q · filed 2012-05-18 | ||||||
| 2011-12-31 | -$1.30M 10-KT/A · filed 2012-11-19 | -$3.69M 10-KT · filed 2012-05-02 | |||||
| 2011-09-30 | $1.55M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $4.64M derived: sum of 2 quarters · filed 2012-11-19 | $3.36M 10-Q · filed 2012-11-19 | $3.02M 10-Q · filed 2011-11-14 | |||
| 2011-06-30 | $3.08M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-21 | $1.81M 10-Q/A · filed 2012-08-21 | $3.04M 10-Q/A · filed 2011-08-24 | ||||
| 2011-03-31 | -$1.28M 10-Q · filed 2012-05-18 | $9.56M 10-KT/A · filed 2012-11-19 | -$4.24M 10-KT · filed 2012-05-02 | ||||
| 2010-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$405.76K 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $931.63K 10-Q/A · filed 2011-12-02 | ||||||
| 2010-03-31 | $49.83K 10-KT/A · filed 2012-11-19 | -$6.36M 10-KT · filed 2012-05-02 |